MELBOURNE, Australia, June 19 /PRNewswire-FirstCall/ -- Phosphagenics
Limited (ASX: POH) (AIM: PSG) (ADR/OTC: PPGNY) announced today that Harry
Rosen, Chief Executive Officer, and Dr. Esra Ogru, Executive Vice
President, will host a table-top presentation around the Jefferies
Healthcare Conference at the conference reception being held at Per Se in
the Time Warner Center in New York on Wednesday, June 27th, 2007 from 5:00
PM to 8:00 PM ET.
In addition, the Company will be available for one-on-one meetings
during the week of the conference.
About Phosphagenics Limited
Phosphagenics is a Melbourne-based, globally driven biotechnology
company focused on the discovery of new and cost effective ways to enhance
the bioavailability, activity, safety and delivery of proven pharmaceutical
and nutraceutical products. The Company's core technology is built around
the science and application of phosphorylation, a process where the
addition of a phosphate group has been found to enhance the
bioavailability, activity and safety of existing pharmaceuticals and
nutraceuticals, as well as to assist in the production of drug delivery
platforms. Phosphagenics' shares are listed on the Australian Stock
Exchange (POH) and the London Stock Exchange's Alternative Investment
Market (PSG). An ADR - Level 1 program has been established in the US with
the Bank of New York (PPGNY) for US investors to trade in Phosphagenics'
stock on the 'over-the-counter' market.
For more information, please visit Phosphagenics' web site at
SOURCE Phosphagenics Limited